Viewing Study NCT01165112


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT01165112
Status: COMPLETED
Last Update Posted: 2018-12-05
First Post: 2010-06-21
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma
Sponsor: University of Washington
Organization: